21st November
Current Perspectives in Haematological Malignancies

DoubleTree by Hilton, Bristol City Centre, Redcliffe Way, Bristol BS1 6NJ


Relapsed CLL: Have the new therapies completely replaced chemotherapy?

Evolution in the management of AML

MRD and blinatumomab
MRD relevance pre and post-transplant

Workshop in Myeloma
Upfront treatments
Relapse in myeloma
Patient-based discussion

New treatments and iron chelation

Lymphoma MDT – Carousel of Cases Chair:
– Managing high risk DLBCL – is there anything better than RCHOP
– Combined modality treatment in early Hodgkin lymphoma
– Refractory late Hodgkin lymphoma
– Managing FL that’s behaving badly

Confirmed Speakers:
· Professor Graham Jackson, NCCC Newcastle
· Dr Ceri Bygrave University Hospital of Wales, Cardiff
· Dr Hannah Hunter University Hospitals Plymouth
· Professor Chris Fegan University Hospital of Wales
· Dr Steve Knapper University Hospital of Wales
· Dr Jonathan Kell University Hospital of Wales
· Dr Andrew McMillan Nottingham University Hospitals
· Dr Steve Robinson University Hospitals Bristol
· Professor Tim Illidge Christie Hospital Manchester
· Dr Wendy Osborne NCCC Newcastle

Registration Fees:

(inclusive of VAT @ 20%)


Trainees / Nurses*

Standard Fee (until 7th November)



Late Fee (from 8th November)



* 20 free places available for Trainees & Nurses (allocated on a first-come, first-served basis – please email meetings@hartleytaylor.co.uk to check availability)

Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF